Accessible Navigation. Go to: Navigation Main Content Footer

All News

Resisting MRSA: Missoula scientists patent drug to treat antibiotic-resistant staph

April 21, 2014

Wes Hale, the company’s managing director and research scientist, formed the company with chief scientific officer Tom Rau in July 2012. Both men hold degrees in molecular biology from the University of Montana, and Rau holds a Ph.D in neuroscience. They’ve been working hard to get their product, a viscous lotion called Solexan, to market. However, they still have a long way to go before they can conduct clinical trials on humans. Helena Independent Record.